abstract |
The invention provides ophthalmic compositions and methods for treating the symptoms of eye allergies. The active ingredient ingredient in these compositions and methods is a macrolide compound, such as tacrolimus, ascomycin and rapamycin and its derivatives. Optimum concentrations and dosing regimens are provided. |